S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CONMED Co. stock logo
CNMD
CONMED
$75.21
+0.8%
$80.51
$73.88
$138.47
$2.32B1.33547,670 shs611,446 shs
InMode Ltd. stock logo
INMD
InMode
$17.69
-1.3%
$21.62
$17.40
$48.25
$1.49B2.161.61 million shs2.20 million shs
LivaNova PLC stock logo
LIVN
LivaNova
$53.37
+0.7%
$53.39
$42.50
$59.86
$2.88B0.89613,111 shs608,803 shs
Masimo Co. stock logo
MASI
Masimo
$138.11
+0.1%
$135.48
$75.22
$198.00
$7.31B0.97592,937 shs452,040 shs
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CONMED Co. stock logo
CNMD
CONMED
+0.84%-4.11%-2.88%-31.90%-31.95%
InMode Ltd. stock logo
INMD
InMode
-1.28%-10.61%-15.40%-17.99%-51.77%
LivaNova PLC stock logo
LIVN
LivaNova
+0.72%-2.43%+5.47%+4.38%+25.31%
Masimo Co. stock logo
MASI
Masimo
+0.14%-3.51%+4.09%+15.00%-27.94%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CONMED Co. stock logo
CNMD
CONMED
4.8473 of 5 stars
3.41.02.54.32.40.04.4
InMode Ltd. stock logo
INMD
InMode
3.1084 of 5 stars
3.23.00.00.02.31.72.5
LivaNova PLC stock logo
LIVN
LivaNova
1.6902 of 5 stars
2.23.00.00.02.21.71.9
Masimo Co. stock logo
MASI
Masimo
3.8271 of 5 stars
2.23.00.04.21.41.72.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CONMED Co. stock logo
CNMD
CONMED
2.86
Moderate Buy$120.4360.12% Upside
InMode Ltd. stock logo
INMD
InMode
2.33
Hold$32.8085.42% Upside
LivaNova PLC stock logo
LIVN
LivaNova
2.40
Hold$64.4020.67% Upside
Masimo Co. stock logo
MASI
Masimo
2.43
Hold$137.43-0.49% Downside

Current Analyst Ratings

Latest MASI, CNMD, INMD, and LIVN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/15/2024
Masimo Co. stock logo
MASI
Masimo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$148.00 ➝ $170.00
4/12/2024
InMode Ltd. stock logo
INMD
InMode
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$34.00 ➝ $33.00
4/9/2024
InMode Ltd. stock logo
INMD
InMode
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
3/27/2024
LivaNova PLC stock logo
LIVN
LivaNova
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$75.00
3/25/2024
Masimo Co. stock logo
MASI
Masimo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$125.00 ➝ $148.00
3/25/2024
Masimo Co. stock logo
MASI
Masimo
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$145.00 ➝ $166.00
3/25/2024
Masimo Co. stock logo
MASI
Masimo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$117.00 ➝ $160.00
3/20/2024
LivaNova PLC stock logo
LIVN
LivaNova
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$72.00
2/26/2024
LivaNova PLC stock logo
LIVN
LivaNova
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$57.00 ➝ $61.00
2/26/2024
Masimo Co. stock logo
MASI
Masimo
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$70.00 ➝ $117.00
2/22/2024
LivaNova PLC stock logo
LIVN
LivaNova
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$56.00 ➝ $62.00
(Data available from 4/16/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CONMED Co. stock logo
CNMD
CONMED
$1.24B1.86$6.10 per share12.32$27.13 per share2.77
InMode Ltd. stock logo
INMD
InMode
$492.05M3.02$2.18 per share8.10$6.68 per share2.65
LivaNova PLC stock logo
LIVN
LivaNova
$1.15B2.50$4.34 per share12.31$23.72 per share2.25
Masimo Co. stock logo
MASI
Masimo
$2.05B3.57$5.77 per share23.93$25.79 per share5.36

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CONMED Co. stock logo
CNMD
CONMED
$64.46M$2.0436.8713.260.685.18%13.69%4.67%4/24/2024 (Confirmed)
InMode Ltd. stock logo
INMD
InMode
$197.92M$2.307.698.04N/A40.22%29.80%27.02%5/2/2024 (Confirmed)
LivaNova PLC stock logo
LIVN
LivaNova
$17.55M$0.32166.7915.93N/A1.53%12.23%6.47%5/1/2024 (Confirmed)
Masimo Co. stock logo
MASI
Masimo
$81.50M$1.5191.4636.44N/A3.98%13.77%5.98%5/14/2024 (Estimated)

Latest MASI, CNMD, INMD, and LIVN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
InMode Ltd. stock logo
INMD
InMode
$0.40N/A-$0.40N/AN/AN/A  
5/1/2024N/A
LivaNova PLC stock logo
LIVN
LivaNova
$0.47N/A-$0.47N/AN/AN/A  
4/24/2024N/A
CONMED Co. stock logo
CNMD
CONMED
$0.74N/A-$0.74N/AN/AN/A  
2/27/2024Q4 2023
Masimo Co. stock logo
MASI
Masimo
$0.82$1.25+$0.43$1.87$545.69 million$548.90 million    
2/21/202412/31/2023
LivaNova PLC stock logo
LIVN
LivaNova
$0.77$0.87+$0.10$1.44$287.65 million$310.10 million    
2/13/202412/31/2023
InMode Ltd. stock logo
INMD
InMode
$0.66$0.71+$0.05$0.64$124.77 million$126.80 million    
1/31/2024Q4 2023
CONMED Co. stock logo
CNMD
CONMED
$1.11$1.06-$0.05$1.07$332.94 million$327.05 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CONMED Co. stock logo
CNMD
CONMED
$0.801.06%N/A39.22%N/A
InMode Ltd. stock logo
INMD
InMode
N/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
Masimo Co. stock logo
MASI
Masimo
N/AN/AN/AN/AN/A

Latest MASI, CNMD, INMD, and LIVN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/26/2024
CONMED Co. stock logo
CNMD
CONMED
quarterly$0.201%3/14/20243/15/20244/5/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CONMED Co. stock logo
CNMD
CONMED
1.17
1.98
0.96
InMode Ltd. stock logo
INMD
InMode
N/A
12.51
11.87
LivaNova PLC stock logo
LIVN
LivaNova
0.44
2.95
2.51
Masimo Co. stock logo
MASI
Masimo
0.64
2.18
1.22

Ownership

Institutional Ownership

CompanyInstitutional Ownership
CONMED Co. stock logo
CNMD
CONMED
N/A
InMode Ltd. stock logo
INMD
InMode
68.04%
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
Masimo Co. stock logo
MASI
Masimo
85.96%

Insider Ownership

CompanyInsider Ownership
CONMED Co. stock logo
CNMD
CONMED
7.60%
InMode Ltd. stock logo
INMD
InMode
6.92%
LivaNova PLC stock logo
LIVN
LivaNova
0.19%
Masimo Co. stock logo
MASI
Masimo
9.70%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
CONMED Co. stock logo
CNMD
CONMED
4,00030.79 million28.45 millionOptionable
InMode Ltd. stock logo
INMD
InMode
58183.98 million78.17 millionOptionable
LivaNova PLC stock logo
LIVN
LivaNova
2,90053.96 million53.85 millionOptionable
Masimo Co. stock logo
MASI
Masimo
5,20052.91 million47.78 millionOptionable

MASI, CNMD, INMD, and LIVN Headlines

SourceHeadline
Stifel Upgrades Masimo (MASI)Stifel Upgrades Masimo (MASI)
msn.com - April 16 at 12:28 AM
Buy Rating Affirmed for Masimo: Strategic Developments and Positive Outlook Signal GrowthBuy Rating Affirmed for Masimo: Strategic Developments and Positive Outlook Signal Growth
markets.businessinsider.com - April 15 at 2:26 PM
Forecasting The Future: 6 Analyst Projections For MasimoForecasting The Future: 6 Analyst Projections For Masimo
markets.businessinsider.com - April 15 at 2:26 PM
Masimo (NASDAQ:MASI) Shares Gap Up to $137.92Masimo (NASDAQ:MASI) Shares Gap Up to $137.92
marketbeat.com - April 15 at 12:52 PM
Masimo (NASDAQ:MASI) Stock Rating Upgraded by Stifel NicolausMasimo (NASDAQ:MASI) Stock Rating Upgraded by Stifel Nicolaus
marketbeat.com - April 15 at 8:16 AM
Is There An Opportunity With Masimo Corporations (NASDAQ:MASI) 24% Undervaluation?Is There An Opportunity With Masimo Corporation's (NASDAQ:MASI) 24% Undervaluation?
finance.yahoo.com - April 14 at 12:30 PM
Arrogant Apple Goes ‘Ape Shit’ Over Watch Ban, With 900+ With Appeal Document That Spews Out Wild Claims Against Masimo & SonosArrogant Apple Goes ‘Ape Shit’ Over Watch Ban, With 900+ With Appeal Document That Spews Out Wild Claims Against Masimo & Sonos
channelnews.com.au - April 10 at 8:36 PM
Masimo To Explore Spin-Off Of Its Consumer UnitMasimo To Explore Spin-Off Of Its Consumer Unit
forbes.com - April 10 at 3:35 PM
A Busy Docket for Device Maker MasimoA Busy Docket for Device Maker Masimo
ocbj.com - April 8 at 4:31 PM
Denon/Marantz/B&W: Is Masimo Poised to Sell its Audio Brands?Denon/Marantz/B&W: Is Masimo Poised to Sell its Audio Brands?
audioholics.com - April 8 at 11:29 AM
Another proxy battle unfolds in the health tech industryAnother proxy battle unfolds in the health tech industry
finance.yahoo.com - April 8 at 6:29 AM
Apple argues Masimo had no competing product against its Watches in over 900-page appeal to US governmentApple argues Masimo had no competing product against its Watches in over 900-page appeal to US government
timesofindia.indiatimes.com - April 6 at 10:52 PM
Apple Urges US Appeals Court to Overturn ITCs Apple Watch Import Ban Amidst Masimo DisputeApple Urges US Appeals Court to Overturn ITC's Apple Watch Import Ban Amidst Masimo Dispute
gadgets360.com - April 6 at 7:50 AM
Assenagon Asset Management S.A. Sells 17,216 Shares of Masimo Co. (NASDAQ:MASI)Assenagon Asset Management S.A. Sells 17,216 Shares of Masimo Co. (NASDAQ:MASI)
marketbeat.com - April 6 at 4:40 AM
Apple asks US appeals court to reverse Apple Watch import banApple asks US appeals court to reverse Apple Watch import ban
finance.yahoo.com - April 5 at 9:03 PM
BREAKING NEWS: Masimo Consumer CEO Quits As Board Members FightBREAKING NEWS: Masimo Consumer CEO Quits As Board Members Fight
channelnews.com.au - April 4 at 7:34 PM
Why Investors Need to Take Advantage of These 2 Medical Stocks NowWhy Investors Need to Take Advantage of These 2 Medical Stocks Now
zacks.com - April 4 at 9:51 AM
Buy Rating Affirmed for Masimo Amid Strategic Split and Enhanced Profitability OutlookBuy Rating Affirmed for Masimo Amid Strategic Split and Enhanced Profitability Outlook
markets.businessinsider.com - April 2 at 11:02 AM
Masimo CEO: Politan wants to oust meMasimo CEO: Politan wants to oust me
msn.com - April 2 at 1:05 AM
Masimo Plans Spinoff Of Consumer BusinessMasimo Plans Spinoff Of Consumer Business
ocbj.com - April 1 at 8:04 PM
Masimo faces another proxy challenge from Politan CapitalMasimo faces another proxy challenge from Politan Capital
finance.yahoo.com - April 1 at 2:56 PM
Masimo Responds to Politan Capital’s Nomination of Director Candidates and Refutes Politan’s False ClaimsMasimo Responds to Politan Capital’s Nomination of Director Candidates and Refutes Politan’s False Claims
finance.yahoo.com - April 1 at 8:24 AM
Raymond James & Associates Sells 22,037 Shares of Masimo Co. (NASDAQ:MASI)Raymond James & Associates Sells 22,037 Shares of Masimo Co. (NASDAQ:MASI)
marketbeat.com - April 1 at 4:31 AM
Masimo Co. (NASDAQ:MASI) Receives Average Rating of "Hold" from AnalystsMasimo Co. (NASDAQ:MASI) Receives Average Rating of "Hold" from Analysts
marketbeat.com - April 1 at 2:15 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

CONMED logo

CONMED

NYSE:CNMD
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
InMode logo

InMode

NASDAQ:INMD
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
LivaNova logo

LivaNova

NASDAQ:LIVN
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
Masimo logo

Masimo

NASDAQ:MASI
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.